Focused Ultrasound and Microbubbles-Mediated Drug Delivery to Brain Tumor

The presence of blood–brain barrier (BBB) and/or blood–brain–tumor barriers (BBTB) is one of the main obstacles to effectively deliver therapeutics to our central nervous system (CNS); hence, the outcomes following treatment of malignant brain tumors remain unsatisfactory. Although some approaches r...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Sheng-Kai, Tsai, Chia-Lin, Huang, Yuexi, Hynynen, Kullervo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7823947/
https://www.ncbi.nlm.nih.gov/pubmed/33374205
http://dx.doi.org/10.3390/pharmaceutics13010015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7823947/
https://www.ncbi.nlm.nih.gov/pubmed/33374205
http://dx.doi.org/10.3390/pharmaceutics13010015

Ejemplares similares